CN102707069A - Immunohistochemical double-antibody kit - Google Patents
Immunohistochemical double-antibody kit Download PDFInfo
- Publication number
- CN102707069A CN102707069A CN201210181365XA CN201210181365A CN102707069A CN 102707069 A CN102707069 A CN 102707069A CN 201210181365X A CN201210181365X A CN 201210181365XA CN 201210181365 A CN201210181365 A CN 201210181365A CN 102707069 A CN102707069 A CN 102707069A
- Authority
- CN
- China
- Prior art keywords
- hrp
- immunoglobulin
- reaction
- activation
- horseradish peroxidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002055 immunohistochemical effect Effects 0.000 title abstract 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 90
- 230000004913 activation Effects 0.000 claims abstract description 45
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 39
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 claims abstract description 39
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 29
- 238000005859 coupling reaction Methods 0.000 claims abstract description 13
- 230000008878 coupling Effects 0.000 claims abstract description 6
- 238000010168 coupling process Methods 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims description 51
- 238000002360 preparation method Methods 0.000 claims description 50
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 claims description 33
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 25
- 229940027941 immunoglobulin g Drugs 0.000 claims description 23
- 239000008363 phosphate buffer Substances 0.000 claims description 21
- 239000012141 concentrate Substances 0.000 claims description 19
- 230000035484 reaction time Effects 0.000 claims description 18
- 210000002966 serum Anatomy 0.000 claims description 18
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 15
- 229940033663 thimerosal Drugs 0.000 claims description 15
- 239000000758 substrate Substances 0.000 claims description 13
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 8
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 7
- 229940098773 bovine serum albumin Drugs 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 230000035945 sensitivity Effects 0.000 abstract 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 32
- 239000007788 liquid Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 28
- 239000000203 mixture Substances 0.000 description 25
- 238000010790 dilution Methods 0.000 description 23
- 239000012895 dilution Substances 0.000 description 23
- 241000283707 Capra Species 0.000 description 21
- 241000283973 Oryctolagus cuniculus Species 0.000 description 20
- 241001494479 Pecora Species 0.000 description 20
- 238000001514 detection method Methods 0.000 description 20
- 229960002163 hydrogen peroxide Drugs 0.000 description 20
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229960002685 biotin Drugs 0.000 description 16
- 235000020958 biotin Nutrition 0.000 description 16
- 239000011616 biotin Substances 0.000 description 16
- 229910021642 ultra pure water Inorganic materials 0.000 description 15
- 239000012498 ultrapure water Substances 0.000 description 15
- 239000012530 fluid Substances 0.000 description 13
- 238000002965 ELISA Methods 0.000 description 12
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000004321 preservation Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000012148 binding buffer Substances 0.000 description 8
- 238000013016 damping Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000000376 reactant Substances 0.000 description 8
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 8
- 101100398282 Mus musculus Kit gene Proteins 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000002372 labelling Methods 0.000 description 7
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 7
- 235000020183 skimmed milk Nutrition 0.000 description 7
- 229940126680 traditional chinese medicines Drugs 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000003119 immunoblot Methods 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 108010090804 Streptavidin Proteins 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 239000007822 coupling agent Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 101710103773 Histone H2B Proteins 0.000 description 3
- 102100021639 Histone H2B type 1-K Human genes 0.000 description 3
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 3
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 3
- 238000001261 affinity purification Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 208000004246 Commotio Cordis Diseases 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000002583 anti-histone Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003805 vibration mixing Methods 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- 208000008636 Neoplastic Processes Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007037 hydroformylation reaction Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000012151 immunohistochemical method Methods 0.000 description 1
- 238000012309 immunohistochemistry technique Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210181365.XA CN102707069B (en) | 2012-06-04 | 2012-06-04 | Immunohistochemical double-antibody kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210181365.XA CN102707069B (en) | 2012-06-04 | 2012-06-04 | Immunohistochemical double-antibody kit |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102707069A true CN102707069A (en) | 2012-10-03 |
CN102707069B CN102707069B (en) | 2015-04-08 |
Family
ID=46900006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210181365.XA Expired - Fee Related CN102707069B (en) | 2012-06-04 | 2012-06-04 | Immunohistochemical double-antibody kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102707069B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103116029A (en) * | 2013-01-29 | 2013-05-22 | 福州迈新生物技术开发有限公司 | Determining method for sensitivity and affinity of second antibody color appearance system for immunohistochemistry |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5232830A (en) * | 1990-05-11 | 1993-08-03 | Microprobe Corporation | Intrinsic fluorescent quenching methods |
CN1504484A (en) * | 2002-12-04 | 2004-06-16 | 沈阳南科专利技术开发公司 | Preparing process for human serum albumin substituted by modified pig serum albumin |
CN101081873A (en) * | 2007-07-09 | 2007-12-05 | 中北大学 | Modified starch using cyanuric chloride as linking radical and preparation method thereof |
CN101424691A (en) * | 2008-12-15 | 2009-05-06 | 北京大学第三医院 | Infiltrative breast carcinoma recurring risk assessment kit |
CN102380347A (en) * | 2010-09-06 | 2012-03-21 | 江南大学 | Cholesterol oxidase affinity matrix, synthesis and large-scale purification method thereof for cholesterol oxidase |
-
2012
- 2012-06-04 CN CN201210181365.XA patent/CN102707069B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5232830A (en) * | 1990-05-11 | 1993-08-03 | Microprobe Corporation | Intrinsic fluorescent quenching methods |
CN1504484A (en) * | 2002-12-04 | 2004-06-16 | 沈阳南科专利技术开发公司 | Preparing process for human serum albumin substituted by modified pig serum albumin |
CN101081873A (en) * | 2007-07-09 | 2007-12-05 | 中北大学 | Modified starch using cyanuric chloride as linking radical and preparation method thereof |
CN101424691A (en) * | 2008-12-15 | 2009-05-06 | 北京大学第三医院 | Infiltrative breast carcinoma recurring risk assessment kit |
CN102380347A (en) * | 2010-09-06 | 2012-03-21 | 江南大学 | Cholesterol oxidase affinity matrix, synthesis and large-scale purification method thereof for cholesterol oxidase |
Non-Patent Citations (11)
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103116029A (en) * | 2013-01-29 | 2013-05-22 | 福州迈新生物技术开发有限公司 | Determining method for sensitivity and affinity of second antibody color appearance system for immunohistochemistry |
CN103116029B (en) * | 2013-01-29 | 2015-01-21 | 福州迈新生物技术开发有限公司 | Determining method for sensitivity and affinity of second antibody color appearance system for immunohistochemistry |
Also Published As
Publication number | Publication date |
---|---|
CN102707069B (en) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI95627C (en) | Method and reagent packaging for determination of endotoxin or a substance similar to endotoxin in a sample and monoclonal antibodies to be used in the method | |
US20080194013A1 (en) | Chromatography Detection Apparatus, Detection Method, and Kit Utilizing the Same | |
CN104105965A (en) | Signal amplification in lateral flow and related immunoassays | |
JPH09511582A (en) | Antibody detection method | |
JP2009085753A (en) | Sandwich immunoassay | |
JPS6120867A (en) | Sandwich test for antibody-lectin | |
Beyzavi et al. | Comparison of horseradish peroxidase and alkaline phosphatase-labelled antibodies in enzyme immunoassays | |
WO2001032908A1 (en) | Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit | |
CN102338804A (en) | Quantitative determination kit for free human chorionic gonadotropin beta subunit (F-beta-HCG) and detection method thereof | |
AU668937B2 (en) | Process for the immunochemical determination of an analyte | |
CN109342718A (en) | A kind of magnetic microparticle chemiluminescence detection method | |
CN102707069A (en) | Immunohistochemical double-antibody kit | |
JPH05223821A (en) | Detection method of microorganism accom- panied by periodontal disease and useful kit therefor | |
JPH05209199A (en) | Kit and method for measuring cleaning composition and for measuring microorganism accompanying periodontosis | |
US20140186861A1 (en) | Soluble treponema pallidum protein tp0453, tp0453-tp0326 fusion protein, and use in syphilis diagnosis | |
EP0217845B1 (en) | Method for the immunological determination of a biological substance in a sample | |
JP4578401B2 (en) | Method for producing immobilized antibody | |
JPH04231872A (en) | Use or protein containing heme as stabilizing agent for enzyme-label immunity reagent | |
WO2022054821A1 (en) | Test reagent with improved specificity by suppressing false negatives | |
WO2022024925A1 (en) | Test reagent with ameliorated signal reduction | |
JPS60186759A (en) | Chromogen carrier immunoassay | |
JP5492158B2 (en) | Antibodies against human TSH and dog TSH | |
JP2004294157A (en) | Method of producing linkage body of gold colloid and antibody | |
CN101038286B (en) | Mercury ion detecting method | |
WO2022054822A1 (en) | Test kit having specificity improved by inhibiting false positives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YIN ZHIMIN Effective date: 20121225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yin Zhimin Inventor after: Feng Zhanbo Inventor after: Zhou Jun Inventor after: Liu Dong Inventor before: Feng Zhanbo Inventor before: Zhou Jun Inventor before: Liu Dong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: FENG ZHANBO ZHOU JUN LIU DONG TO: YIN ZHIMIN FENG ZHANBO ZHOU JUN LIU DONG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121225 Address after: Qixia District Maigaoqiao street Nanjing city Jiangsu province 210036 and Yan Road No. 251 Building 1 building 1202 room 18 Applicant after: Nanjing Baaode Bio-technology Co.,Ltd. Applicant after: Yin Zhimin Address before: Qixia District Maigaoqiao street Nanjing city Jiangsu province 210036 and Yan Road No. 251 Building 1 building 1202 room 18 Applicant before: Nanjing Baaode Bio-technology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150408 Termination date: 20210604 |